Logo image of HLBN.DE

HOLCIM LTD (HLBN.DE) Stock Fundamental Analysis

FRA:HLBN - Deutsche Boerse Ag - CH0012214059 - Common Stock - Currency: EUR

102.1  +1.2 (+1.19%)

Fundamental Rating

5

Taking everything into account, HLBN scores 5 out of 10 in our fundamental rating. HLBN was compared to 12 industry peers in the Construction Materials industry. HLBN scores excellent on profitability, but there are some minor concerns on its financial health. HLBN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year HLBN was profitable.
In the past year HLBN had a positive cash flow from operations.
Each year in the past 5 years HLBN has been profitable.
Each year in the past 5 years HLBN had a positive operating cash flow.
HLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFHLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.38%, HLBN is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
HLBN has a better Return On Equity (10.73%) than 75.00% of its industry peers.
HLBN's Return On Invested Capital of 7.46% is fine compared to the rest of the industry. HLBN outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HLBN is in line with the industry average of 7.82%.
The 3 year average ROIC (6.46%) for HLBN is below the current ROIC(7.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.38%
ROE 10.73%
ROIC 7.46%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
HLBN.DE Yearly ROA, ROE, ROICHLBN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

HLBN has a Profit Margin of 11.07%. This is amongst the best in the industry. HLBN outperforms 83.33% of its industry peers.
In the last couple of years the Profit Margin of HLBN has grown nicely.
HLBN has a Operating Margin of 16.58%. This is amongst the best in the industry. HLBN outperforms 91.67% of its industry peers.
In the last couple of years the Operating Margin of HLBN has grown nicely.
Looking at the Gross Margin, with a value of 44.22%, HLBN is in line with its industry, outperforming 41.67% of the companies in the same industry.
HLBN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.58%
PM (TTM) 11.07%
GM 44.22%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
HLBN.DE Yearly Profit, Operating, Gross MarginsHLBN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

HLBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for HLBN has been reduced compared to 1 year ago.
Compared to 5 years ago, HLBN has less shares outstanding
The debt/assets ratio for HLBN has been reduced compared to a year ago.
HLBN.DE Yearly Shares OutstandingHLBN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
HLBN.DE Yearly Total Debt VS Total AssetsHLBN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

HLBN has an Altman-Z score of 2.86. This is not the best score and indicates that HLBN is in the grey zone with still only limited risk for bankruptcy at the moment.
HLBN has a better Altman-Z score (2.86) than 75.00% of its industry peers.
The Debt to FCF ratio of HLBN is 3.45, which is a good value as it means it would take HLBN, 3.45 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.45, HLBN is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
A Debt/Equity ratio of 0.44 indicates that HLBN is not too dependend on debt financing.
HLBN's Debt to Equity ratio of 0.44 is in line compared to the rest of the industry. HLBN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.45
Altman-Z 2.86
ROIC/WACC1.61
WACC4.62%
HLBN.DE Yearly LT Debt VS Equity VS FCFHLBN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

HLBN has a Current Ratio of 1.25. This is a normal value and indicates that HLBN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.25, HLBN is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
HLBN has a Quick Ratio of 1.25. This is a bad value and indicates that HLBN is not financially healthy enough and could expect problems in meeting its short term obligations.
HLBN has a worse Quick ratio (0.93) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.93
HLBN.DE Yearly Current Assets VS Current LiabilitesHLBN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2

3. Growth

3.1 Past

HLBN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.24%.
The Earnings Per Share has been growing slightly by 7.24% on average over the past years.
HLBN shows a decrease in Revenue. In the last year, the revenue decreased by -2.23%.
Measured over the past years, HLBN shows a decrease in Revenue. The Revenue has been decreasing by -0.24% on average per year.
EPS 1Y (TTM)-2.24%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%-3.15%
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-2.5%

3.2 Future

HLBN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.58% yearly.
The Revenue is expected to grow by 0.15% on average over the next years.
EPS Next Y10.1%
EPS Next 2Y7.51%
EPS Next 3Y8.35%
EPS Next 5Y4.58%
Revenue Next Year1.97%
Revenue Next 2Y3.05%
Revenue Next 3Y3.53%
Revenue Next 5Y0.15%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HLBN.DE Yearly Revenue VS EstimatesHLBN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
HLBN.DE Yearly EPS VS EstimatesHLBN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.26 indicates a rather expensive valuation of HLBN.
HLBN's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of HLBN to the average of the S&P500 Index (25.91), we can say HLBN is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.77, HLBN is valued correctly.
HLBN's Price/Forward Earnings ratio is in line with the industry average.
HLBN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.26
Fwd PE 14.77
HLBN.DE Price Earnings VS Forward Price EarningsHLBN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HLBN is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, HLBN is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.77
EV/EBITDA 9.98
HLBN.DE Per share dataHLBN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HLBN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.81
PEG (5Y)2.52
EPS Next 2Y7.51%
EPS Next 3Y8.35%

4

5. Dividend

5.1 Amount

HLBN has a Yearly Dividend Yield of 3.23%. Purely for dividend investing, there may be better candidates out there.
HLBN's Dividend Yield is comparable with the industry average which is at 3.51.
HLBN's Dividend Yield is a higher than the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 3.23%

5.2 History

The dividend of HLBN is nicely growing with an annual growth rate of 39.59%!
Dividend Growth(5Y)39.59%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

53.73% of the earnings are spent on dividend by HLBN. This is a bit on the high side, but may be sustainable.
The dividend of HLBN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP53.73%
EPS Next 2Y7.51%
EPS Next 3Y8.35%
HLBN.DE Yearly Income VS Free CF VS DividendHLBN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
HLBN.DE Dividend Payout.HLBN.DE Dividend Payout, showing the Payout Ratio.HLBN.DE Dividend Payout.PayoutRetained Earnings

HOLCIM LTD

FRA:HLBN (5/26/2025, 7:00:00 PM)

102.1

+1.2 (+1.19%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)04-25 2025-04-25
Earnings (Next)07-31 2025-07-31
Inst Owners40.64%
Inst Owner ChangeN/A
Ins Owners6.59%
Ins Owner ChangeN/A
Market Cap59.13B
Analysts70.37
Price Target103.87 (1.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.23%
Yearly Dividend3.03
Dividend Growth(5Y)39.59%
DP53.73%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.26
Fwd PE 14.77
P/S 2.09
P/FCF 13.77
P/OCF 9.76
P/B 2.03
P/tB 5.39
EV/EBITDA 9.98
EPS(TTM)5.59
EY5.48%
EPS(NY)6.91
Fwd EY6.77%
FCF(TTM)7.41
FCFY7.26%
OCF(TTM)10.46
OCFY10.24%
SpS48.74
BVpS50.27
TBVpS18.95
PEG (NY)1.81
PEG (5Y)2.52
Profitability
Industry RankSector Rank
ROA 5.38%
ROE 10.73%
ROCE 9.83%
ROIC 7.46%
ROICexc 8.47%
ROICexgc 14.95%
OM 16.58%
PM (TTM) 11.07%
GM 44.22%
FCFM 15.21%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
ROICexc(3y)7.58%
ROICexc(5y)7.02%
ROICexgc(3y)13.04%
ROICexgc(5y)11.56%
ROCE(3y)8.52%
ROCE(5y)7.98%
ROICexcg growth 3Y12.63%
ROICexcg growth 5Y13.6%
ROICexc growth 3Y7.66%
ROICexc growth 5Y8.99%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.45
Debt/EBITDA 1.88
Cap/Depr 81.89%
Cap/Sales 6.25%
Interest Coverage 8.17
Cash Conversion 88.64%
Profit Quality 137.47%
Current Ratio 1.25
Quick Ratio 0.93
Altman-Z 2.86
F-Score6
WACC4.62%
ROIC/WACC1.61
Cap/Depr(3y)149.39%
Cap/Depr(5y)143.09%
Cap/Sales(3y)11.07%
Cap/Sales(5y)11.4%
Profit Quality(3y)72.22%
Profit Quality(5y)84.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.24%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%-3.15%
EPS Next Y10.1%
EPS Next 2Y7.51%
EPS Next 3Y8.35%
EPS Next 5Y4.58%
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-2.5%
Revenue Next Year1.97%
Revenue Next 2Y3.05%
Revenue Next 3Y3.53%
Revenue Next 5Y0.15%
EBIT growth 1Y2.46%
EBIT growth 3Y3.69%
EBIT growth 5Y5.91%
EBIT Next Year43.61%
EBIT Next 3Y16.89%
EBIT Next 5Y-2.18%
FCF growth 1Y101.86%
FCF growth 3Y238.03%
FCF growth 5Y4.99%
OCF growth 1Y3.6%
OCF growth 3Y3.95%
OCF growth 5Y3.27%